Should You Buy Mazor Robotics Ltd. (MZOR) On Current Analyst Views?

Cornelia Mascio
Agosto 31, 2017

First Analysis lowered shares of Mazor Robotics from an overweight rating to an equal weight rating and increased their price target for the company from $28.00 to $38.00 in a research note on Thursday, May 11th. Investors will be watching to see if the name can maintain momentum heading into the new year.Since the start of the calendar year, Mazor Robotics Ltd. (NASDAQ:MZOR)'s stock has changed 116.29%. They noted that the move was a valuation call. The stock of Mazor Robotics Ltd - ADR (NASDAQ:MZOR) earned "Reduce" rating by Standpoint Research on Wednesday, April 19. This indicates more upside for the $1.10B company.

TRADEMARK VIOLATION WARNING: "Mazor Robotics Ltd. (MZOR) Given a $54.00 Price Target at Ladenburg Thalmann Financial Services" was originally posted by StockNewsTimes and is owned by of StockNewsTimes. With 961,200 shares average volume, it will take short sellers 2 days to cover their MZOR's short positions. Shares have hit a new 52-week high after reaching $48.00 during recent trading action. The company's 50-day moving average is $38.90 and its 200-day moving average is $33.40. Mazor Robotics had a negative return on equity of 28.51% and a negative net margin of 37.66%. The firm's revenue was up 86.7% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.09) earnings per share.

Now the shares of Mazor Robotics Ltd. (MZOR) has the trading volume of 1.4 Million shares with the average trading volume of 400940 shares. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & global trademark & copyright laws.

Mazor Robotics Ltd. (MZOR) has a market capitalization of 1.14 Billion which suggests the company is a huge company further suggesting that the shares of Mazor Robotics Ltd. (MZOR) are stable and safe compared to the lower market capitalization companies.

A number of hedge funds have recently added to or reduced their stakes in MZOR.

05/11/2017 - Mazor Robotics Ltd. was downgraded to "market perform" by analysts at Wells Fargo. Wells Fargo & Company MN now owns 40,958 shares of the medical instruments supplier's stock valued at $1,220,000 after buying an additional 12,959 shares in the last quarter. Menora Mivtachim Holdings LTD. raised its stake in Mazor Robotics by 57.2% in the first quarter. The firm now has a buy rating on the medical instruments supplier's stock. The medical instruments supplier reported ($0.16) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.25) by $0.09. Hedge funds and other institutional investors own 27.52% of the company's stock.

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE